US9394363B2 - Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof - Google Patents

Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof Download PDF

Info

Publication number
US9394363B2
US9394363B2 US13/685,899 US201213685899A US9394363B2 US 9394363 B2 US9394363 B2 US 9394363B2 US 201213685899 A US201213685899 A US 201213685899A US 9394363 B2 US9394363 B2 US 9394363B2
Authority
US
United States
Prior art keywords
antibody
rage
seq id
binding
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US13/685,899
Other versions
US20130149313A1 (en
Inventor
JiJie Gu
Chung-Ming Hsieh
Zhen Wu
Enrico L. DiGiammarino
Feng Luo
Gerard B. FOX
John E. Harlan
Martin Schmidt
Ralf LOEBBERT
Reinhold Mueller
Ulrich Ebert
Volker Nimmrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Deutschland GmbH and Co KG
AbbVie Inc
Original Assignee
AbbVie Deutschland GmbH and Co KG
AbbVie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US5186308P priority Critical
Priority to US9341608P priority
Priority to US12/437,715 priority patent/US8323651B2/en
Application filed by AbbVie Deutschland GmbH and Co KG, AbbVie Inc filed Critical AbbVie Deutschland GmbH and Co KG
Priority to US13/685,899 priority patent/US9394363B2/en
Publication of US20130149313A1 publication Critical patent/US20130149313A1/en
Assigned to ABBVIE DEUTSCHLAND GMBH & CO KG reassignment ABBVIE DEUTSCHLAND GMBH & CO KG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ABBOTT GMBH & CO KG
Assigned to ABBVIE INC. reassignment ABBVIE INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ABBOTT LABORATORIES
Assigned to ABBOTT GMBH & CO. KG reassignment ABBOTT GMBH & CO. KG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LOEBBERT, RALF, EBERT, ULRICH, MUELLER, REINHOLD, NIMMRICH, VOLKER, SCHMIDT, MARTIN
Assigned to ABBOTT LABORATORIES reassignment ABBOTT LABORATORIES ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HSIEH, CHUNG-MING, LUO, FENG, FOX, GERARD B., DIGIAMMARINO, ENRICO L., GU, JIJIE, WU, ZHEN, HARLAN, JOHN E.
Publication of US9394363B2 publication Critical patent/US9394363B2/en
Application granted granted Critical
Application status is Active legal-status Critical
Adjusted expiration legal-status Critical

Links